share_log

西藏药业(600211.SH):目前暂时没有研发川穹、红景天、黄芪的组合型中成药

Tibet Pharmaceutical (600211.SH): Currently, there are no proprietary Chinese medicines in combination with Chuanqiong, Rhodiola, and Astragalus

Gelonghui Finance ·  Dec 27, 2023 02:55

Gelonghui, December 27丨Tibet Pharmaceutical (600211.SH) said on the investor interactive platform that the company is currently not developing the combined proprietary Chinese medicine of Chuanqiong, Rhodiola, and Astragalus.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment